For Investors
Benefits of massive for investors
Massive has the potential to be extremely beneficial for investors looking to become involved in the biotech research and development industry. Massive will connect the web of investors, contractors, research institutes and organisations, to increase the cohesiveness of research within the biotech industry. The benefits for investors include:
​
-
Reduced Risks – assessment of all aspects of development.
-
Reduce costs/ overheads from outsourcing and multiple
-
Accelerate time to market.
-
Optimising clinical and financial outcomes from improved 
-
Likelihood of approval
-
Clinical uptake
-
Reimbursement
Investment assisted by massive
Research discovery
Due diligence and external research
Investment within the massive ecosystem
Massive connects current innovative research and development, managing business and creating a portfolio of research and development that informs recommendations for investors.
Massive conducts due diligence and market research to ensure the quality of research and development conducted through massive, thus ensuring the quality of work produced. This provides peace of mind and outsourced due diligence and market research for investors.
By continuing investment through massive, investors can be sure of the quality of research and development. As a result investors will be introduced to the biotech research and development ecosystem created by massive.